METANDREN Drug Patent Profile
✉ Email this page to a colleague
When do Metandren patents expire, and what generic alternatives are available?
Metandren is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in METANDREN is methyltestosterone. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyltestosterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metandren
A generic version of METANDREN was approved as methyltestosterone by IMPAX LABS on December 31st, 1969.
Summary for METANDREN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Patent Applications: | 4,964 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METANDREN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for METANDREN
US Patents and Regulatory Information for METANDREN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | METANDREN | methyltestosterone | TABLET;BUCCAL, SUBLINGUAL | 003240-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |